The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Markus B SkrifvarsNora LuethiMichael BaileyCraig FrenchAlistair NicholTony TrapaniColin McArthurYaseen M ArabiStepani BendelDavid J CooperRinaldo Bellomonull nullPublished in: Intensive care medicine (2023)
EPO neither decreased overall long-term mortality nor improved functional outcome in moderate or severe TBI patients treated in the intensive care unit (ICU). The limited sample size makes it difficult to make final conclusions about the use of EPO in TBI.